CITIGROUP INC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,000
-50.0%
2,010
-44.4%
0.00%
Q1 2022$4,000
-92.6%
3,616
-78.1%
0.00%
Q4 2021$54,000
+25.6%
16,526
+70.3%
0.00%
Q3 2021$43,000
+22.9%
9,702
+49.5%
0.00%
Q2 2021$35,000
+9.4%
6,489
+50.9%
0.00%
Q1 2021$32,000
-97.7%
4,301
-96.7%
0.00%
-100.0%
Q4 2020$1,400,000
+2313.8%
129,003
+1873.4%
0.00%
Q3 2020$58,000
-92.3%
6,537
-90.7%
0.00%
-100.0%
Q2 2020$752,000
+902.7%
70,502
+458.3%
0.00%
Q1 2020$75,000
+5.6%
12,627
+23.4%
0.00%
Q4 2019$71,000
+82.1%
10,236
+175.0%
0.00%
Q3 2019$39,000
-60.6%
3,722
-65.2%
0.00%
Q2 2019$99,000
+45.6%
10,694
+45.2%
0.00%
Q1 2019$68,000
+88.9%
7,367
+13.5%
0.00%
Q4 2018$36,000
-56.6%
6,489
-6.6%
0.00%
Q3 2018$83,000
+232.0%
6,948
+260.7%
0.00%
Q1 2018$25,000
+1150.0%
1,926
+867.8%
0.00%
Q4 2017$2,000
+100.0%
199
+139.8%
0.00%
Q2 2017$1,000
-50.0%
83
-33.1%
0.00%
Q1 2017$2,000
-60.0%
124
-67.5%
0.00%
Q3 2016$5,0003810.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders